What is the average price target for VOLITIONRX LTD (VNRX) stock?
11 analysts have analysed VNRX and the average price target is 2.1 USD. This implies a price increase of 1118.79% is expected in the next year compared to the current price of 0.1724.
NYSEARCA:VNRX • US9286611077
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VOLITIONRX LTD (VNRX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-03-31 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-03-26 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-03-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-09 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-04 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-03 | Maxim Group | Downgrade | Buy -> Hold |
| 2025-11-26 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-17 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-29 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-10 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-17 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-09 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-10 | Jones Trading | Initiate | Buy |
| 2025-04-30 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-08 | HC Wainwright & Co. | Initiate | Buy |
| 2025-04-01 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-31 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-20 | D. Boral Capital | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 775.3K 150.10% | 1.234M 59.10% | 1.727M 40.04% | 10.017M 479.89% | 63.95M 538.41% | 122.25M 91.16% | 176.53M 44.40% | 241.77M 36.96% | 284.78M 17.79% | 342.47M 20.26% | 388.34M 13.39% | |
| EBITDA YoY % growth | -34.835M -12.95% | -25.912M 25.62% | -20.755M 19.90% | -9.84M 52.59% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -35.988M -13.24% | -27.025M 24.90% | -21.739M 19.56% | -14.009M 35.56% | 26.944M 292.34% | 91.38M 239.15% | 153.45M 67.93% | 218.32M 42.27% | 260.58M 19.36% | 317.48M 21.84% | 361.76M 13.95% | |
| Operating Margin | -4,641.78% | -2,190.92% | -1,258.46% | -139.85% | 42.13% | 74.75% | 86.93% | 90.30% | 91.50% | 92.70% | 93.16% | |
| EPS YoY % growth | -0.51 7.27% | -0.31 39.22% | -0.22 28.39% | -0.10 56.81% | 0.18 291.49% | 0.35 92.59% | 0.63 78.84% | 0.87 37.10% | 0.96 10.59% | 1.09 13.30% | 1.16 7.04% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.04 36.25% | -0.04 36.25% | -0.03 38.80% | -0.03 46.06% |
| Revenue Q2Q % growth | 714K 190.24% | 889.95K 118.66% | 985.575K 57.12% | 1.14M 155.02% |
| EBITDA Q2Q % growth | -3.294M 37.50% | -2.698M 53.43% | -2.176M 49.96% | -1.673M 56.38% |
| EBIT Q2Q % growth | -4.968M 10.03% | -5.049M 19.83% | -4.708M 7.70% | -4.501M 6.60% |
All data in USD
11 analysts have analysed VNRX and the average price target is 2.1 USD. This implies a price increase of 1118.79% is expected in the next year compared to the current price of 0.1724.
VOLITIONRX LTD (VNRX) will report earnings on 2026-05-13.
The consensus EPS estimate for the next earnings of VOLITIONRX LTD (VNRX) is -0.04 USD and the consensus revenue estimate is 714.00K USD.
The consensus rating for VOLITIONRX LTD (VNRX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.